Eisai Co Ltd – Page 3

Health

Biogen isn’t concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says

Newsology2 years ago06 mins

[ad_1] A person skateboards past Biogen Inc. headquarters in Cambridge, Massachusetts, on Monday, June 7, 2021. Adam Glanzman | Bloomberg | Getty Images Biogen isn’t worried about competing with Eli Lilly as they both attempt to bring an Alzheimer’s drug to the market, Biogen’s CEO said Tuesday. “I think it will be good if there…

Health

Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says

Newsology2 years ago09 mins

[ad_1] Research at Biogen Source: Biogen Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai shows. The Japanese drugmaker and its partner Biogen last week released an additional analysis of clinical trials of the monoclonal antibody drug, which is also known as lecanemab. Alzheimer’s disease continued to progress at a slower…